Mycophenolate Mofetil (Cellcept) Uses

Mycophenolate mofetil is used to prevent organ rejection in people who have received a heart, liver, or kidney transplant.

There may be other uses of mycophenolate mofetil, such as for treating Crohn’s disease—your healthcare professionals can give you further drug information.

Mycophenolate Mofetil (Cellcept) Mechanism of Action

Mycophenolate mofetil weakens the body’s immune system and prevents it from attacking the newly transplanted organ.

Mycophenolate Mofetil (Cellcept) Doses

Mycophenolate mofetil is available as a 500 mg tablet, 180 mg and 360 mg delayed-release tablets (Myfortic), 250 mg capsule, powder for 200 mg/mL oral suspension, and solution for intravenous injection. The recommended doses are as follows in adults:

• Kidney transplant patients: 1 gram twice daily (2 grams total daily dose).
• Heart transplant patients: 1.5 grams twice daily (3 grams total daily dose).
• Liver transplant patients: 1.5 grams twice daily (3 grams total daily dose).

In pediatric patients, the dose of mycophenolate mofetil is calculated based on body surface area.

The dose of mycophenolic acid (Myfortic) delayed-release tablets in adult kidney transplant patients is 720 mg twice daily (1,440 mg total daily dose).